Interim results from a phase 1/2 precision medicine study of PLX8394- a next generation BRAF inhibitor

SIOG COVID-19 working group report and discussion of ethical issues

OncoAlert and ecancer weekly roundup for November 2 - 7, 2020

Evolving concepts in the diagnosis and staging of multiple myeloma

Recommendations on treating multiple myeloma patients during the pandemic

SAFIR 02: Durvalumab compared to maintenance chemotherapy for metastatic non-small cell lung cancer

PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer

Sotorasib for advanced non-small cell lung cancer

CaRE2 Cancer Research Link©: Social Determinants of Health on Cancer Outcomes in Black Populations

VHL/HIF and VEGF inhibitors in clear cell renal cell carcinoma

Prospective validation of single mouse testing by the paediatric preclinical testing consortium

Bevacizumab-induced hypertension and proteinuria: A genome-wide analysis of more than 1,000 patients